Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and Cash Equivalents $ 93,823 $ 749,090
Marketable Securities 11,533,432 4,086,902
Prepaid Expenses 1,515,760 565,787
Total Current Assets 13,143,015 5,401,779
Non-Current Assets    
Operating Lease Right-of-Use Assets 107,571 139,662
Goodwill 10,498,539 10,498,539
Investment in Oravax, Inc. 1,500,000 1,500,000
Total Non-Current Assets 12,106,110 12,138,201
Total Assets 25,249,125 17,539,980
Current Liabilities    
Trade and Other Payables 2,156,452 2,673,221
Operating Lease Liability 70,287 65,780
Dividends Payable 172,387
Total Current Liabilities 2,429,108 2,768,983
Non-Current Liabilities    
Operating Lease Liability, net of current portion 39,505 75,941
Derivative Liabilities 3,465,000
Warrant Liabilities 7,813,000
Total Non-Current Liabilities 11,317,505 75,941
Total Liabilities 13,746,613 2,844,924
Commitments and Contingencies  
STOCKHOLDERS’ EQUITY    
Common stock, no par value, 500,000,000 shares authorized 42,027,113 and 39,470,009 issued and outstanding as of June 30, 2023 and December 31, 2022 110,567,664 108,309,436
Accumulated Deficit (99,970,418) (93,758,904)
Total Stockholders’ Equity 10,741,770 14,695,056
Total Liabilities and Stockholders’ Equity 25,249,125 17,539,980
Series F Convertible Preferred Stock [Member]    
Non-Current Liabilities    
Series F Convertible Preferred Stock, 15,000 shares designated, no par value and a stated value of $1,000 per share, 12,500 and 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022. Liquidation preference of $12,500,000 plus dividends at 10% per annum of $172,387 as of June 30, 2023. 760,742
Series D Convertible Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock value 144,524 144,524
Related Party [Member]    
Current Liabilities    
Due to MyMD Florida Shareholders $ 29,982 $ 29,982